MedTrace Logo

Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting

NCT01482468 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2012-03-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether continuous infusion of palonosetron after its prophylactic single injection can further reduce the incidence of postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

continuous infusion of palonosetron added to prophylactic single injection of palonosetron

continuous infusion of palonosetron 0.00075 mg/hour after single injection of palonosetron 0.075mg

DRUG

continuous infusion of normal saline added to prophylactic single injection of palonosetron

continuous infusion of normal saline after single injection of palonosetron 0.075mg

Sponsors & Collaborators

  • Incheon St.Mary's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01482468 on ClinicalTrials.gov